logo
IMPROVED SURVIVAL IN PATIENTS WITH INSULIN-DEPENDENT DIABETES MELLITUS AND END-STAGE DIABETIC NEPHROPATHY 10 YEARS AFTER COMBINED PANCREAS AND KIDNEY TRANSPLANTATION1
HYDROCORTISONE ACTIVATION OF HUMAN HERPESVIRUS 8 VIRAL DNA REPLICATION AND GENE EXPRESSION IN VITRO1
INJECTION OF MITOMYCIN-C-TREATED SPLEEN CELLS INDUCES DONOR-SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS1
SERUM CYTOTOXICITY TO PIG CELLS AND ANTI-αGAL ANTIBODY LEVEL AND SPECIFICITY IN HUMANS AND BABOONS
REVERSAL OF HYPERGLYCEMIA IN MICE AFTER SUBCUTANEOUS TRANSPLANTATION OF MACROENCAPSULATED ISLETS1
TEMPORAL SEQUENCE OF TRANSCRIPTION OF PERFORIN, FAS LIGAND, AND TUMOR NECROSIS FACTOR-α GENES IN REJECTING SKIN ALLOGRAFTS1
ACUTE BLEEDING AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION: ASSOCIATION WITH GRAFT VERSUS HOST DISEASE AND EFFECT ON SURVIVAL1
PATHOLOGIC CLASSIFICATION OF CHRONIC ALLOGRAFT NEPHROPATHY: PATHOGENIC AND PROGNOSTIC IMPLICATIONS1
IMPACT OF TRANSFUSIONS AND ACUTE REJECTION ON POSTTRANSPLANTATION DONOR ANTIGEN-SPECIFIC RESPONSES IN TWO STUDY POPULATIONS1,2
THROMBOCYTOPENIA AFTER LIVER TRANSPLANTATION
FOUR-YEAR FOLLOW-UP OF MYCOPHENOLATE MOFETIL FOR GRAFT RESCUE IN LIVER ALLOGRAFT RECIPIENTS1
LONG-TERM OUTCOME OF LIVING RELATED LIVER TRANSPLANTATION FOR PATIENTS WITH INTRAPULMONARY SHUNTING AND STRATEGY FOR COMPLICATIONS1,2
LONG-TERM FOLLOW-UP OF LIVING KIDNEY DONORS: QUALITY OF LIFE AFTER DONATION1
A COMPARISON OF RECIPIENT RENAL OUTCOMES WITH LAPAROSCOPIC VERSUS OPEN LIVE DONOR NEPHRECTOMY
A RANDOMIZED MULTICENTER TRIAL OF THE ANTI-ICAM-1 MONOCLONAL ANTIBODY (ENLIMOMAB) FOR THE PREVENTION OF ACUTE REJECTION AND DELAYED ONSET OF GRAFT FUNCTION IN CADAVERIC RENAL TRANSPLANTATION
THE CLINICAL USEFULNESS OF THE RENAL ALLOGRAFT BIOPSY IN THE CYCLOSPORINE ERA
CD2 AND CD3 RECEPTOR-MEDIATED TOLERANCE
NEONATAL PIG ISLETS INDUCE A LOWER T-CELL RESPONSE THAN ADULT PIG ISLETS IN IDDM PATIENTS1
INFLUENZA VACCINATION IN LIVER TRANSPLANT RECIPIENTS
NOVEL MUTATION IN THE CMV UL97 GENE ASSOCIATED WITH RESISTANCE TO GANCICLOVIR THERAPY
ABSENCE OF TERATOGENICITY OF ORAL GANCICLOVIR USED DURING EARLY PREGNANCY IN A LIVER TRANSPLANT RECIPIENT
THE IMMUNOSUPPRESSIVE AGENT MYCOPHENOLATE MOFETIL MARKEDLY POTENTIATES THE ACTIVITY OF LOBUCAVIR [1R(1α,2β,3α)]-9-[2,3-BIS(HYDROXYMETHYL)-CYCLOBUTYL]GUANINE AGAINST DIFFERENT HERPES VIRUSES1
TREATMENT OF EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER WITH FOSCARNET ALONE IN AN ADULT AFTER SIMULTANEOUS HEART AND RENAL TRANSPLANTATION
INTRACRANIAL PRESSURE DURING LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE1
POSTTRANSPLANT DIABETES IN PEDIATRIC RECIPIENTS ON TACROLIMUS
ANNOUNCEMENTS